iSpecimen (ISPC) Return on Sales (2020 - 2026)

iSpecimen's Return on Sales history runs 7 years deep, the most recent figure standing at 0.16% for Q1 2026.

• In Q1 2026, Return on Sales fell 15.0% year-over-year to 0.16%; the TTM figure through Mar 2026 stood at 0.1% (down 8.0% YoY), while the FY2025 annual figure was 0.05%, down 3.0% from the prior year.
• Return on Sales was 0.16% for Q1 2026 at iSpecimen, up from 0.52% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.01% in Q3 2024 to a low of 0.52% in Q4 2025.
• Historically, Return on Sales has averaged 0.07% across 5 years, with a median of 0.01% in 2022.
• The sharpest annual moves came in 2024 and 2025: Return on Sales gained 1 bps in 2024, then plunged 48 bps in 2025.
• A 5-year view of Return on Sales shows it stood at 0.01% in 2022, then sank by 51 bps to 0.01% in 2023, then plunged by 270 bps to 0.04% in 2024, then tumbled by 1178 bps to 0.52% in 2025, then surged by 69 bps to 0.16% in 2026.
• The last three Return on Sales figures came in at 0.16% (Q1 2026), 0.52% (Q4 2025), and 0.27% (Q3 2025), per Business Quant data.